Latest AI and machine learning research in oncology/hematology for healthcare professionals.
OBJECTIVE: To develop and externally validate an integrated model that combines multimodality CT-MRI deep learning with clinical and radiological features for noninvasive preoperative hepatocellular carcinoma (HCC) histologic grading, and to evaluate whether this integration outperforms single-modality imaging, the multimodality imaging model alone, and a clinical-radiological model. METHODS: In t...
Esophageal squamous cell carcinoma (ESCC) is characterized by substantial intratumoral heterogeneity and poor clinical prognosis. Although metalloproteins are well-documented to drive ESCC malignant progression, incomplete functional annotation of this protein family significantly impedes the clinical translation of related research outcomes. This study reports the development and validation of a ...
NADPH oxidases (NOXs) have emerged as central hubs that link environmental, metabolic, and immune cues through spatially organized redox signaling. Ho...
Cervical cancer is a leading preventable cause of cancer morbidity and mortality globally. Previous studies have indicated that dysregulation of the u...
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignant cancer with limited biomarkers for early detection and disease stratification. He...
OBJECTIVES: Cervical cancer is a leading female malignancy with high global morbidity/mortality, and remains high recurrence risk after standard treat...
Technology-assisted implant positioning has emerged as a strategy to improve component placement accuracy in total hip arthroplasty (THA). However, th...
INTRODUCTION: Posttranslational modification (PTM) plays an important role in protein regulation and may influence tumor initiation and progression. H...
Deep learning models are increasingly used to analyze medical images, but their "black box" nature makes it hard to understand the underlying biology ...
Radiation enteritis (RE) is a severe, dose-limiting complication of cancer radiotherapy that affects the therapeutic outcomes of patients and their qu...
Programmed death-ligand 1 (PD-L1) expression, commonly quantified as tumour proportion score (TPS), is a key biomarker guiding immunotherapy in non-sm...
BACKGROUND: Actinic cheilitis (AC) is a potentially malignant oral disorder linked to lip squamous cell carcinoma (LSCC). Clinical diagnosis is hinder...
BACKGROUND: Optimizing adjuvant chemotherapy (AC) for gastric cancer (GC) remains challenging due to patient heterogeneity. While the lymph node ratio...
Neoantigens are tumor-specific antigens resulting from genetic, transcriptomic, and proteomic changes, making them a promising avenue for personalized...
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains highly lethal, and genome-centric precision oncology shows limited impact due to low actio...
BACKGROUND: Hepatocellular carcinoma (HCC) is characterized by marked heterogeneity and an immunosuppressive microenvironment in which tumor-associate...
BACKGROUND: Ovarian cancer remains the deadliest gynecological malignancy, with neoadjuvant chemotherapy (NACT) often leaving residual fibroblast-enri...
INTRODUCTION: The integration of artificial intelligence (AI) tools into radiation therapy workflows offers significant opportunities to improve effic...
BACKGROUND & AIMS: Immunochemotherapy (IO-chemo) has become standard care for patients with unresectable intrahepatic cholangiocarcinoma (iCCA), but b...
OBJECTIVES: Preoperative prediction of perineural invasion (PNI) in rectal cancer (RC) is challenging due to limited MRI resolution and the neglect of...